The future of healthcare is being reshaped by a wave of data-driven discovery, unleashing limitless potential for medical breakthroughs. With technology that enables unbounded access to vast, interconnected patient-level datasets, the healthcare industry is empowered to explore the complex fabric of human health in ways previously unimaginable. We’re now able to pull a needle from a haystack – finding and, with the right technology, extracting the most specific data we need. No longer constrained by data silos, fragmented and incomplete patient journeys, researchers can delve deep into real-world evidence, with advanced AI and ML-algorithms by their side.
A prime example of this game-changing, technology-driven access to high-quality data for clinical innovation is Briya’s recent collaboration with MSD – a global leader in pharmaceuticals that wanted to utilize RWD to deepen research into 3 critical diseases.
How MSD Leveraged Briya’s Medical Data Retrieval Network for Research
Merck Sharp & Dohme has long been at the forefront of scientific discovery, investing significant amounts of time and resources into clinical research to drive pharmaceutical innovation. Yet, a key area that MSD, like any life-science company, was struggling with was the simple lack of tools to access and translate the vast amount of available real-world data into actionable insight. Data silos, fragmented systems, incomplete patient records, and outdated data proved to be a significant burden – costing time and money, while failing to provide MSD’s researchers with a convenient and reliable source of information.
The decision to join forces with Briya was apparent. The collaboration allowed MSD to leverage Briya’s advanced medical data retrieval network and empower their researchers to access and analyze diverse data with unprecedented precision. Briya’s ability to combine and unify data from different types of sources incl. EMR, imaging, labs to ready-to-use standardized datasets is changing the game in analyzing complex real-world evidence (RWE). Together, MSD and Briya provided a more complete view of the patient journey and key insights into disease progression, treatment efficacy, and healthcare outcomes.
Providing MSD’s pharmaceutical experts with our advanced data capabilities, we were able to drive meaningful clinical insights that have the potential to revolutionize patient care and treatment outcomes.
State-of-the-Art Technology to Unlock The Power of RWE
Briya’s solution is unique in many ways, one of them being our Natural Language Processing (NLP) Suite which is able to extract real-world data from unstructured data sources, including free text and clinical notes. Being able to combine data from these previously neglected sources, MSD achieved an entirely new level of data-quality and completeness.
This access to various data sources facilitated a more nuanced understanding of patient outcomes, including highly accurate insights into treatment, medication, and long-term effects. Briya ensures the data is of the highest quality possible, both in regards to completeness and representativeness, using AI-enhanced insights and optimization suggestions. With seamless, real-time access to rich, diverse datasets pulled directly from healthcare organizations’ information systems – free from the previous limitations on data availability – instead of waiting their time on trying to find data, researchers can focus on deeper analysis, apply AI and machine learning models, and uncover patterns that would have remained hidden in the past.
Briya platform’s ability to integrate and harmonize anonymized data across multiple sources while ensuring the highest standards of security and privacy compliance played a crucial role in the success of this initiative. Briya’s commitment to data integrity (led by our Chief Epidemiology Officer, Prof. Siegal Sadetzki) and patient privacy ensured that every step of the collaboration was in line with regulatory standards, safeguarding sensitive information while delivering impactful results.
The Future of Data-Driven Research
This collaboration is not only a success story for Briya and MSD but also a reflection of the broader role data-driven research will play in the near future of healthcare. As healthcare becomes increasingly data-driven, we are committed to pioneering innovative research solutions that enhance the understanding of diseases and drive better patient outcomes. The strategic collaboration between Briya and MSD is just the beginning. Through partnerships like this, we will continue to shape the future of medical research by harnessing the power of real-world data.
Related articles
Unlocking Insights from RWD: An Interview with Dr. Or Shaked on Briya’s NLP-Driven Study for ISPOR Europe
As Briya prepares to present at ISPOR Europe 2024 (mark...
Read more
Turning Hospitals Into Active Participants in Pharmaceutical Research
Today, data is one of the most valuable assets hospital...
Read more
5 Ways Real-Time Data is Revolutionizing Clinical Trials: Accelerating Research and Boosting ROI
Even though clinical trials are essential for gaining i...
Read more
